Mrs Annmarie Hotchkiss, LCSW, LICSW | |
77 Mill St, Westfield, MA 01085-4598 | |
(413) 568-1421 | |
Not Available |
Full Name | Mrs Annmarie Hotchkiss |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 77 Mill St, Westfield, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093716326 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 005085 (Connecticut) | Secondary |
1041C0700X | Social Worker - Clinical | 116339 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Annmarie Hotchkiss, LCSW, LICSW 51 Holland Ave, Westfield, MA 01085-3730 Ph: (413) 297-5564 | Mrs Annmarie Hotchkiss, LCSW, LICSW 77 Mill St, Westfield, MA 01085-4598 Ph: (413) 568-1421 |
News Archive
Delcath Systems, Inc., which is testing its proprietary treatment system for metastatic cancers to the liver, announced today that the U.S. Food and Drug Administration ("FDA") will allow the Company to initiate an Expanded Use – Intermediate Size Population protocol for the hepatic arterial infusion of melphalan with venous filtration via the Delcath PHP System™ for patients with ocular and cutaneous melanoma metastatic to the liver.
Researchers from the National Institutes of Health and other institutions have identified in mice two proteins essential for ovulation to take place.
Researchers have long recognized that for learning and memory to take place, certain genes must be activated to alter neuron activity inside the brain.
In an unanticipated finding, researchers at the UC Davis School of Medicine have discovered that, during early adulthood, the brain produces new excitatory neurons, and that these neurons arise from non-neuronal support cells in an area of the brain that processes smell.
On January 26, 2010, the Food and Drug Administration (FDA) released a key draft guidance document, Guidance for Industry Assessment of Abuse Potential of Drugs. When finalized, this guidance will represent the FDA's current position on the abuse potential of drugs. Noteworthy within the document, Good Laboratory Practices (GLP) specified in the Guidance for Industry S7A Safety 471 Pharmacology Studies for Human Pharmaceuticals and in FDA regulations, 21 CFR 472 part 58, now also apply to abuse potential studies in animals.
› Verified 4 days ago
Emily Sanchez, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 77 Mill St, Westfield, MA 01085 Phone: 413-568-6141 | |
Susanne Emerle, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 91 Elm St, Westfield, MA 01085 Phone: 413-572-4111 | |
Julianne Stasiowski, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 77 Mill St, Suite 251, Westfield, MA 01085 Phone: 413-568-6141 | |
Patricia Jalette, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 77 Mill St, Suite 251, Westfield, MA 01085 Phone: 413-568-6141 | |
Pamela Wordsworth, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 91 Elm St, Westfield, MA 01085 Phone: 413-572-4111 | |
Frank Hunter, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 77 Mill St, Westfield, MA 01085 Phone: 413-572-4111 | |
Mariah Strattner, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 77 Mill St, Westfield, MA 01085 Phone: 413-568-6141 |